Bristol-Myers Squibb Company (BMY) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Bristol-Myers Squibb Company, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$60.57
−1.59% today
Market cap
$125.7B
Overall quality
55/100
Kronos AI 30-day
+3.4%
6 of 8 simulated paths end higher
Bristol-Myers Squibb Company (BMY) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $125.7B. It trades at $60.57, down 1.59% today, at 13.3 times earnings. Its overall quality score is 55 out of 100, ranked against the whole US market. 21 analysts' average target of $66.14 implies +9.2% from today's price. Kronos AI's 30-day forecast is +3.4% (6 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $66.14 |
| Low – high | $41.00 – $80.00 |
| Analysts | 21 |
| Upside to average | +9.2% |
Kronos AI 30-day forecast
| Expected close | $63.62 (+3.4%) |
| Likely range | −1.4% … +7.8% |
| As of | 2026-10-27 |
6 of 8 simulated paths end higher.
Quality scores
| Profitability | 84 |
| Solvency | 34 |
| Growth | 46 |
| Overall | 55 |
| P/E | 13.3 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.